Company intelligence / Profile preview

UPnRIDE Robotics

Yokneam Illit, Haifa District, Israelupnride.com ↗

Ownership: Private
Development stage: Commercial

Overview

The flagship product—the UPnRIDE—has received US FDA clearance and EU CE Mark. It enables safe upright and seated mobility on various terrains for people with disabilities. Clinical results are not detailed in public sources but the device has demonstrated significant benefits in independence, health outcomes, psychological well-being, and reduction of medical costs.

No drug clinical trials; the focus is on regulatory-cleared assistive devices.

Therapeutic areas: Neurology
Modalities: DeviceRobotic mobility deviceNon-pharmacological therapy (assistive/rehabilitation)
Industry: Assistive Medical Devices

Beyond the preview

Go deeper on UPnRIDE Robotics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on UPnRIDE Robotics.

Explore the full profile